Alan Fournier's portfolio and holdings - Jan 2024

As per corporate shareholdings filed for , people matching Alan Fournier publicly holds 36 stocks with a net worth of over US$ 445.2 M.

These are shares held by Alan Fournier as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

Add Superstar Alert
Stock Name Holders Name Current Price US$ Quantity Held Holding Percent Change from Previous Qtr Holding Value US$ History
Agenus Inc Pennant Investors Lp 6.35 469,600 0.11% NEW 3.0 M
Agios Pharmaceuticals Inc Pennant Investors Lp 37.20 15,100 0.03% NEW 561.7 K
Allogene Therapeutics Inc Pennant Investors Lp 1.47 128,400 0.08% NEW 188.7 K
Altimmune Inc Pennant Investors Lp 4.03 109,800 0.15% NEW 442.5 K
Amazon.com Inc. Pennant Investors Lp 232.79 348,000 0.00% 0.00 81.0 M
Arcturus Therapeutics Holdings Inc Pennant Investors Lp 14.38 13,100 0.05% NEW 188.4 K
Arcutis Biotherapeutics Inc Pennant Investors Lp 14.96 170,900 0.15% NEW 2.6 M
BioXcel Therapeutics Inc Pennant Investors Lp 1.70 83,900 0.23% NEW 142.6 K
Coherus Biosciences Inc Pennant Investors Lp 1.07 168,100 0.15% NEW 179.9 K
Compass Therapeutics Inc Pennant Investors Lp 3.20 199,000 0.14% NEW 636.8 K
Enanta Pharmaceuticals Inc Pennant Investors Lp 8.03 35,100 0.17% NEW 281.9 K
Erasca Inc Pennant Investors Lp 1.70 166,200 0.11% NEW 282.5 K
89bio Inc Pennant Investors Lp 9.54 44,500 0.05% NEW 424.5 K
Fate Therapeutics Inc Pennant Investors Lp 1.30 146,100 0.13% NEW 189.9 K
FibroGen Inc Pennant Investors Lp 7.21 768,400 0.77% NEW 5.5 M
Alphabet Inc - Ordinary Shares - Class A Pennant Investors Lp 192.58 375,000 0.00% 0.00 72.2 M
IGM Biosciences Inc Pennant Investors Lp 1.26 64,900 0.11% NEW 81.8 K
Kalaris Therapeutics Inc. Pennant Investors Lp 2.92 215,700 0.19% NEW 629.8 K
Seres Therapeutics Inc Pennant Investors Lp 13.24 292,300 0.19% NEW 3.9 M
Macrogenics Inc Pennant Investors Lp 1.67 43,800 0.07% NEW 73.1 K
Microsoft Corporation Pennant Investors Lp 512.50 129,000 0.00% 0.00 66.1 M
Micron Technology Inc. Pennant Investors Lp 111.25 306,000 0.03% 0.00 34.0 M
Nurix Therapeutics Inc Pennant Investors Lp 11.93 56,800 0.09% NEW 677.6 K
Novavax, Inc. Pennant Investors Lp 7.28 60,300 0.04% NEW 439.0 K
ODP Corporation (The) Pennant Investors Lp 18.07 400,000 1.10% 0.02 7.2 M
uniQure N.V. Pennant Investors Lp 14.98 48,500 0.10% NEW 726.5 K
Replimune Group Inc Pennant Investors Lp 3.17 30,500 0.05% NEW 96.7 K
Relay Therapeutics Inc Pennant Investors Lp 3.70 42,400 0.03% NEW 156.9 K
Sage Therapeutics Inc Pennant Investors Lp 8.78 17,500 0.03% NEW 153.7 K
EchoStar Corp - Ordinary Shares - Class A Pennant Investors Lp 29.77 2,153,209 0.79% NEW 64.1 M
Travere Therapeutics Inc Pennant Investors Lp 15.40 55,800 0.07% NEW 859.3 K
Zentalis Pharmaceuticals Inc Pennant Investors Lp 1.44 32,400 0.05% NEW 46.7 K
Zymeworks BC Inc Pennant Investors Lp 13.46 38,700 0.05% NEW 520.9 K
Antero Resources Corp Pennant Investors Lp 32.65 913,000 0.29% -0.01 29.8 M
Arcus Biosciences Inc Pennant Investors Lp 9.85 23,700 0.03% NEW 233.4 K
Transdigm Group Incorporated Pennant Investors Lp 1606.39 42,000 0.08% 0.00 67.5 M
View All The Superstar Shareholder Portfolios